Danish J. Qureshi Sells 150,000 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Danish J. Qureshi sold 150,000 shares of LifeStance Health Group stock in a transaction on Friday, June 14th. The stock was sold at an average price of $5.21, for a total value of $781,500.00. Following the sale, the insider now directly owns 439,002 shares of the company’s stock, valued at approximately $2,287,200.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

LifeStance Health Group Stock Up 1.0 %

Shares of LFST stock opened at $5.29 on Wednesday. The business’s 50 day simple moving average is $6.17 and its 200 day simple moving average is $6.58. LifeStance Health Group, Inc. has a one year low of $4.74 and a one year high of $9.59. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.20.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Thursday, May 9th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.03. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. The business had revenue of $300.44 million for the quarter, compared to analysts’ expectations of $299.02 million. During the same period in the prior year, the business posted ($0.09) earnings per share. The firm’s revenue was up 18.9% on a year-over-year basis. As a group, equities analysts anticipate that LifeStance Health Group, Inc. will post -0.26 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently commented on LFST. Barclays boosted their price target on LifeStance Health Group from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Thursday, February 29th. Morgan Stanley reissued an “overweight” rating and set a $10.00 target price on shares of LifeStance Health Group in a research note on Monday, April 22nd. Jefferies Financial Group boosted their target price on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. Finally, The Goldman Sachs Group boosted their target price on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a research note on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $8.80.

Hedge Funds Weigh In On LifeStance Health Group

Several institutional investors have recently added to or reduced their stakes in the business. ProShare Advisors LLC lifted its stake in LifeStance Health Group by 8.5% in the first quarter. ProShare Advisors LLC now owns 19,069 shares of the company’s stock valued at $118,000 after buying an additional 1,500 shares during the period. Assetmark Inc. raised its position in shares of LifeStance Health Group by 21.6% during the fourth quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock worth $93,000 after purchasing an additional 2,114 shares during the period. Bessemer Group Inc. raised its position in LifeStance Health Group by 43.4% in the 1st quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock valued at $56,000 after buying an additional 2,768 shares during the last quarter. SG Americas Securities LLC raised its position in LifeStance Health Group by 8.7% in the 1st quarter. SG Americas Securities LLC now owns 44,925 shares of the company’s stock valued at $277,000 after buying an additional 3,600 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in LifeStance Health Group by 12.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 42,366 shares of the company’s stock valued at $262,000 after purchasing an additional 4,681 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.